What diagnosis code should be used for a patient taking lorazepam who requires a urine drug screen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Diagnosis Code for Urine Drug Screen in Patients Taking Lorazepam

For a patient prescribed lorazepam who requires a urine drug screen, use diagnosis codes that reflect the clinical indication for testing: either medication compliance monitoring (Z79.899 for long-term benzodiazepine use) or substance use screening/monitoring codes (Z13.89 for screening, or F11.10-F19.10 series if substance use disorder is suspected).

Clinical Context and Coding Strategy

The appropriate diagnosis code depends entirely on why you are ordering the urine drug screen, not simply that the patient takes lorazepam:

For Compliance Monitoring

  • Z79.899 (Other long-term drug therapy) - Use when monitoring adherence to prescribed lorazepam
  • This is appropriate when you need to verify the patient is taking their prescribed benzodiazepine and not diverting it
  • The CDC guideline 1 explicitly recommends urine drug testing "before starting opioid therapy and consider urine drug testing at least annually" for patients on controlled substances, and this principle extends to benzodiazepine monitoring

For Substance Use Screening

  • Z13.89 (Encounter for screening for other disorder) - Use for general substance use screening
  • F11.10-F19.10 series - Use if you suspect concurrent substance use disorder (specific code depends on suspected substance)
  • The guideline 2 notes that routine toxicologic screening in psychiatric patients should be "directed by the history and physical examination" rather than performed universally

For Concurrent Opioid Use

  • If the patient is on both lorazepam and opioids, document both the benzodiazepine use (Z79.899) and opioid use (Z79.891)
  • The CDC guideline 1 emphasizes that "concurrent use of opioid pain medications with other opioid pain medications, benzodiazepines, or heroin can increase patients' risk for overdose"
  • Testing is particularly justified given the FDA warning 3 that "concomitant use of benzodiazepines, including lorazepam, and opioids may result in profound sedation, respiratory depression, coma, and death"

Key Clinical Considerations

Insurance Coverage: The diagnosis code directly impacts reimbursement. Research shows 4 that ICD-10-CM codes for substance use have "high specificity and low sensitivity," meaning insurers scrutinize these claims carefully. Choose the most clinically accurate code that reflects your documented medical necessity.

Testing Limitations:

  • Standard benzodiazepine immunoassays may not detect all benzodiazepines equally 5
  • Lorazepam glucuronide requires beta-glucuronidase hydrolysis for optimal detection
  • Detection window for lorazepam in urine is typically 24-48 hours 6

Documentation Requirements:

  • Document the specific clinical indication (compliance monitoring, concern for polysubstance use, pre-procedural screening)
  • Note any concerning behaviors: early refill requests, lost prescriptions, or signs of intoxication 1
  • If results will influence treatment decisions, document this prospectively

Common Pitfalls

Avoid using psychiatric diagnosis codes alone (F41.x for anxiety) without a substance-related code, as this may not justify the drug screen to payers.

Do not routinely order screens without clinical indication 2. The guideline states that "routine laboratory testing of all patients is of very low yield and need not be performed as part of the ED assessment" in stable psychiatric patients.

Be aware of false negatives: The lorazepam FDA label 3 notes that "some patients on lorazepam have developed leukopenia" and recommends "periodic blood counts and liver-function tests for patients on long-term therapy," but does not specifically address urine monitoring frequency.

References

1
Guideline

prevention and control of seasonal influenza with vaccines.

MMWR Recommendations and Reports, 2016

Related Questions

Is oral lorazepam (Ativan) administered 30 minutes before a procedure effective?
Is a 1 mg oral dose of lorazepam (Ativan) equivalent to a 1 mg intravenous dose?
What is the appropriate intramuscular dose of lorazepam (Ativan) for an adult patient?
How should lorazepam (Ativan) be administered intramuscularly, including appropriate dosing, injection site, and safety precautions?
How can I prescribe a 0.25 mg dose of lorazepam for a 70‑year‑old female when the tablets are not available in that strength?
What stronger antibiotic is appropriate for an adult with a cracked lower molar and an odontogenic infection that has not responded to standard amoxicillin?
In an autistic patient with bipolar disorder who has tics causing a shiver and anxiety, how should lamotrigine be dosed, and is buspirone (Buspar) appropriate for additional anxiety control?
What is the recommended antibiotic therapy for a patient with a cracked lower molar presenting with lymphadenopathy and malaise, and what alternative should be used if the patient has a severe penicillin allergy?
Should prophylactic antibiotics be administered for endocarditis prevention during colonoscopy with biopsies, including in patients with high‑risk cardiac conditions such as prosthetic heart valves or prior infective endocarditis?
What is the recommended evaluation and management for optic nerve hypoplasia?
For an adult patient with a wound infection whose culture and sensitivity shows susceptibility to amoxicillin‑clavulanate and who has no systemic symptoms, what dosage and duration should be prescribed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.